Core Laboratories (CLB) Current Leases (2022 - 2026)

Core Laboratories' Current Leases history runs 5 years deep, the most recent figure standing at $12.1 million for Q1 2026.

• On a quarterly basis, Current Leases rose 3.8% year-over-year to $12.1 million in Q1 2026; TTM through Mar 2026 was $12.1 million, a 3.8% increase from a year earlier, with the FY2025 full-year figure at $11.5 million, up 7.17% from the prior year.
• Current Leases advanced to $12.1 million in Q1 2026 per CLB's latest filing, from $11.5 million in the prior quarter.
• Across five years, Current Leases topped out at $12.1 million in Q1 2026 and bottomed at $9.8 million in Q3 2023.
• The 5-year median for Current Leases is $11.4 million (2024), against an average of $11.1 million.
• Across the five-year window, Current Leases retreated 13.03% in 2023 and gained 16.76% in 2024, its largest moves.
• Year by year, Current Leases stood at $11.7 million in 2022, then declined by 13.03% to $10.2 million in 2023, then climbed by 5.06% to $10.7 million in 2024, then increased by 7.17% to $11.5 million in 2025, then increased by 5.6% to $12.1 million in 2026.
• Per Business Quant, the three latest CLB Current Leases figures stand at $12.1 million (Q1 2026), $11.5 million (Q4 2025), and $11.5 million (Q3 2025).